Goldiam International Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/3x4kv3h4a4xsnr0s778461s3.pdf

Key Takeaways


Lab-Grown Diamond Strategy

Anmol Bhansali: "Today and even for, I believe, the foreseeable future, Goldiam is the only jewellery entity which is fully backwards integrated into lab-grown diamonds. So, whenever you look at us, you have to analyze us from the angle and viewpoint of a jewellery company first rather than a loose diamond company doing a little bit of jewellery here."

Demand Environment & Revenue

Rashesh Bhansali: "I'm sure you will see a certain decline in the coming quarter. But yes, we will do better than the previous quarter that you're currently seeing, and we will try to make up some of the losses, but there will be a decline. But the good part is that I don't see any decline in profitability."

Inventory & Working Capital


New Initiatives & Geographic Expansion

Anmol Bhansali: "Costs and pricing for Lab Grown Diamonds have come off already and have come down to a level where I believe there is not too much room left for further decreases in terms of even just comparing with the hard operational costs of growing."

Competitive Position & Distribution


Guidance & Commitments

CommitmentSpecificsTimeline
LGD capacity expansionDouble capacity with another 25 machines at ~₹75 lakhs eachScaling up within the next two quarters
Electricity cost reductionWorking with Adani Electricity for a reduced rate; expect to hear back with confirmed lower rate, which would achieve parity with Surat growersEnd of December to beginning of January
Inventory rundownSignificant rundown of the nearly ₹300 crore inventory; ₹150 crore order book to be executedNext six months
Domestic India LGD retail launchOpen own stores, sell retail via omnichannel, items priced ₹50,000–3,00,000Next calendar year; more detail next call
Geographic expansionEnter EU and Europe, and Australia with wholesalers and retailersNext year
LGD revenue mixLab-grown to move closer to 50% of the mixNext 3–4 years
Near-term revenueCertain decline in the coming quarter, but narrower than Q2; no decline in profitabilityComing quarter
US macro pain durationInterest rate pain expected to persistAnother two quarters, assuming one or two more hikes then softening or continuing

Key Metrics

MetricQ2 FY23
Revenue29% decline consolidated YoY
H1 PATStable on a YoY basis
Order book>₹150 cr, expected execution within 4–6 months, excludes online orders
Net cash balance₹150 cr
Lab-grown share of jewellery exports25% to 28%
Lab-grown share of order book25%
Lab-grown share of inventory30%, up from 14–15% in September end quarter last year
Total inventory~₹300 cr, includes goods shipped to US distribution office awaiting billing
Lab-grown diamond capacity (machines installed)25 machines, cost per machine ~₹75 lakhs
CAPEX for lab-grown capacity enhancement₹10 cr
Natural diamond jewellery price increase15% to 20% depending on clients
Mined diamond cost of goods increase25% to 35% depending on buying quality
Lab-grown diamond margins>40% (analyst's statement, management did not confirm)
Online business as a percentage of revenue~20%
Average selling price to customer$550 to $600
Jewel Fleet as a percentage of total sales2% to 2.5%
Jewel Fleet retailers serviced350 to 400
Lab-grown selling price vs natural1/5 to 1/4 of natural selling price